Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Psoriasis: Contemporary and Future Therapies, An Issue of Dermatologic Clinics
- 1st Edition, Volume 42-3 - May 28, 2024
- Editor: Jeffrey M. Cohen
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 2 9 2 7 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 2 9 2 8 - 5
In this issue of Dermatologic Clinics, guest editor Dr. Jeffrey M. Cohen brings his considerable expertise to the topic of Psoriasis: Contemporary and Future Therapies… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Dermatologic Clinics, guest editor Dr. Jeffrey M. Cohen brings his considerable expertise to the topic of Psoriasis: Contemporary and Future Therapies. Top experts in the field discuss oral therapies for psoriasis; phototherapy for psoriasis in the era of biologics; the psoriasis treatment pipeline; psoriasis comorbidities and their impact on treatment; underdiagnosis and undertreatment of traditional cardiovascular risk factors in psoriasis; and much more.
- Contains 14 relevant, practice-oriented topics including biologics for psoriasis; psoriasis genetics and the impact of genetics on comorbidities and treatment; psoriasis therapies in the pediatric population; disparities in psoriasis treatment; immune checkpoint inhibitor-induced psoriasis; and more.
- Provides in-depth clinical reviews on psoriasis: contemporary and future therapies, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Dermatology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Erratum
- Preface
- Biologics for Psoriasis
- Key points
- Introduction
- Biologic classes
- Discussion
- Summary
- Clinics care points
- Oral Psoriasis Therapies
- Key points
- Introduction
- Traditional immune suppressants or immunomodulatory therapy for psoriasis
- Newer targeted immunomodulators
- Clinics care points
- The Psoriasis Treatment Pipeline: An Overview and Update
- Key points
- Introduction
- Brief overview of psoriatic disease features and immunopathogenesis
- Topical therapies
- Oral therapies
- Biologic therapies
- Summary
- Evolving Landscape of Biologic Therapy for Pediatric Psoriasis
- Key points
- Introduction
- Management
- Tumor necrosis factor-α inhibitors
- Interleukin-17 Inhibitors
- Interleukin-12/23 and Interleukin-23 Inhibitors
- Summary
- Clinics care points
- Treatment of Nail Psoriasis
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Phototherapy for Psoriasis in the Age of Biologics
- Key points
- Background: pathophysiology of phototherapy for psoriasis
- Initial therapy selection
- Comparative efficacy
- Onset of action
- Risks and contraindications
- Potential for remission
- Access and cost
- Special considerations
- Summary
- Clinics care points
- Psoriasis Comorbidities and Their Treatment Impact
- Key points
- Introduction
- Psoriatic arthritis
- Cardiovascular disease
- Metabolic syndrome
- Inflammatory bowel disease
- Ocular disease
- Mental health
- Other considerations
- Clinics care points
- Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis
- Key points
- Introduction
- Impact of psoriasis treatment on cardiovascular risk
- Importance of treating modifiable cardiovascular risk factors
- Current US guidelines on cardiovascular risk in people with psoriasis
- Gaps in practice and the role of dermatologists
- Screening for cardiovascular risk factors in routine dermatologic care of psoriasis
- Summary
- Clinics care points
- Prevention of Psoriatic Arthritis: The Need for Prospective Studies
- Key points
- Introduction
- Summary
- Clinics care points
- The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response
- Key points
- Introduction
- Genetics
- Psoriasis comorbidities
- Pharmacogenetics
- Discussion
- Summary
- Clinics care points
- Paradoxical Psoriasis
- Key points
- Introduction
- Epidemiology and natural history of disease
- Genetic associations
- Clinical features of paradoxical psoriasis
- Histopathologic features of paradoxical psoriasis
- Pathogenic mechanism
- Management of paradoxical psoriasis
- Summary
- Clinics care points
- Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases
- Key points
- Introduction
- Diagnosis
- Management
- Effect on immune checkpoint inhibitor continuation and antitumor response
- Discussion
- Summary
- Clinics care points
- Adherence to Psoriasis Therapies
- Key points
- Introduction
- Factors associated with nonadherence
- Primary adherence
- Secondary adherence: topical therapies
- Secondary adherence: phototherapy
- Secondary adherence: systemic therapies
- Secondary adherence: observations during the coronavirus pandemic
- Suggestions for improving adherence: primary adherence
- Suggestions for improving adherence: secondary adherence
- Experimental trials in the literature
- Discussion
- Summary
- Clinics care points
- Disparities in Care for Psoriasis
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 42-3
- Published: May 28, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443129278
- eBook ISBN: 9780443129285
JC
Jeffrey M. Cohen
Affiliations and expertise
Director, Psoriasis Treatment Program
Assistant Professor
Department of Dermatology
Yale School of Medicine